AI Verdict
HCA has stronger fundamentals based on our AI analysis.
ABT vs HCA Fundamental Comparison
| Metric | ABT | HCA |
|---|---|---|
| Revenue | $11.2B | $19.1B |
| Net Income | $1.1B | $1.6B |
| Net Margin | 9.6% | 8.5% |
| ROE | 2.1% | N/A |
| ROA | 1.0% | 2.6% |
| Current Ratio | 1.39x | 0.83x |
| Debt/Equity | 0.57x | N/A |
| EPS | $0.61 | $7.15 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs HCA: Frequently Asked Questions
Is ABT or HCA the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HCA has stronger fundamentals. ABT is graded B (74% confidence) while HCA is graded A (76% confidence). This is not investment advice.
How does ABT compare to HCA fundamentally?
ABBOTT LABORATORIES has ROE of 2.1% vs HCA Healthcare, Inc.'s N/A. Net margins are 9.6% vs 8.5% respectively.
Which stock pays higher dividends, ABT or HCA?
ABT has a dividend yield of N/A or no dividend while HCA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or HCA for long term?
For long-term investing, consider that ABT has a B grade with 74% confidence, while HCA has a A grade with 76% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs HCA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs HCA, the AI consensus favors HCA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.